These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28444271)

  • 1. Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis.
    Alkhalil M; Choudhury RP
    JAMA; 2017 Apr; 317(16):1690-1691. PubMed ID: 28444271
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis.
    Murray SW
    JAMA; 2017 Apr; 317(16):1690. PubMed ID: 28444270
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis-Reply.
    Nicholls SJ; Somaratne R; Nissen SE
    JAMA; 2017 Apr; 317(16):1691. PubMed ID: 28444274
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive detection of atherosclerosis.
    Celermajer DS
    N Engl J Med; 1998 Dec; 339(27):2014-5. PubMed ID: 9869674
    [No Abstract]   [Full Text] [Related]  

  • 5. [HMA CoA reductase inhibitors].
    Kostner GM
    Wien Med Wochenschr; 1999; 149(5-6):109-10. PubMed ID: 10408000
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal lipids, statins, and dementia.
    Lavie CJ; Milani RV
    J Am Coll Cardiol; 2005 Mar; 45(6):963-4; author reply 964-5. PubMed ID: 15766838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of statins on coronary artery disease. Review of the recent publications].
    Bednarz B
    Przegl Lek; 2003; 60(1):27-9. PubMed ID: 12884643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of antibiotics and statins on inflammation in coronary disease.
    Stojanović R; Vasiljević Z; Prostran M; Radovanović M; Stefanović B; Radovanović N; Janković J; Lakicević M; Mitrović P; Lasica R; Nesić Z; Todorović Z; Stojanov M
    Vojnosanit Pregl; 2005 Sep; 62(9):661-70. PubMed ID: 16229209
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins targeting inflammation by lowering low-density lipoprotein?
    Tuzcu EM; Nicholls SJ
    J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive lipid-lowering therapy and regression of coronary atheroma.
    Ravnskov U; Sutter MC
    JAMA; 2004 Jul; 292(1):38; author reply 39-40. PubMed ID: 15238580
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggressive lipid-lowering therapy and regression of coronary atheroma.
    Rosch PJ
    JAMA; 2004 Jul; 292(1):38-9; author reply 39-40. PubMed ID: 15238581
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction. Review of major recent findings supporting treatments to control advanced plaques of atherosclerosis.
    Insull W
    Am J Med; 2009 Jan; 122(1 Suppl):S1-2. PubMed ID: 19110083
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggressive lipid-lowering therapy and regression of coronary atheroma.
    Rajaram K
    JAMA; 2004 Jul; 292(1):39; author reply 39-40. PubMed ID: 15238582
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive lipid-lowering therapy and regression of coronary atheroma.
    van der Harst P; van Gilst WH; Zijlstra F
    JAMA; 2004 Jul; 292(1):39; author reply 39-40. PubMed ID: 15238583
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
    Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE
    JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention].
    Thomas HP; Kassner U; Steinhagen-Thiessen E
    MMW Fortschr Med; 2000 Jul; 142(30):33-4. PubMed ID: 10955017
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?].
    Müller-Wieland D; Faust M; Schleifenbaum T; Krone W
    MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in coronary artery disease: beyond cholesterol reduction.
    Gambhir DS; Gambhir J
    Indian Heart J; 1997; 49(3):257-61. PubMed ID: 9291645
    [No Abstract]   [Full Text] [Related]  

  • 19. Moderate LDL cholesterol reduction with statins shows similar benefit to aggressive lipid lowering in ischaemic heart disease.
    Mayor S
    BMJ; 2016 Jun; 353():i3437. PubMed ID: 27335335
    [No Abstract]   [Full Text] [Related]  

  • 20. What vitamins should I be taking?
    Blackman BT
    N Engl J Med; 2002 Jun; 346(24):1914-6; author reply 1914-6. PubMed ID: 12063381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.